Mepolizumab

CAS No. 196078-29-2

Mepolizumab( SB 240563 )

Catalog No. M28987 CAS No. 196078-29-2

Mepolizumab is a humanized monoclonal antibody neutralizing IL-5. Mepolizumab can be used in studies about severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 758 Get Quote
10MG 1044 Get Quote
25MG 1557 Get Quote
50MG 2097 Get Quote
100MG 2817 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Mepolizumab
  • Note
    Research use only, not for human use.
  • Brief Description
    Mepolizumab is a humanized monoclonal antibody neutralizing IL-5. Mepolizumab can be used in studies about severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.
  • Description
    Mepolizumab is a humanized monoclonal antibody neutralizing IL-5. Mepolizumab can be used in studies about severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SB 240563
  • Pathway
    Apoptosis
  • Target
    IL Receptor
  • Recptor
    Adenine phosphoribosyltransferase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    196078-29-2
  • Formula Weight
    ——
  • Molecular Formula
    ——
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Borrmann T, et al. Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family. J Med Chem. 2009 Oct 8;52(19):5974-89.
molnova catalog
related products
  • 5-O-Caffeoylshikimic...

    5-O-Caffeoylshikimic acid shows anti-oxidative activity; it also shows anti-inflammatory activity, the underlying mechanism was associated with downregulation of nuclear factor-κB.

  • Daclizumab

    Daclizumab (Zenapax) is a humanized monoclonal antibody that specifically inhibits the alpha subunit of IL-2R-HA.

  • Ordesekimab

    Ordesekimab (AMG 714) is a human IgG1 κ-anti-IL-15 (Interleukin Related) monoclonal antibody.